These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10482797)

  • 41. Evaluation of the oxidation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) to toxic pyridinium cations by monoamine oxidase (MAO) enzymes and its use to search for new MAO inhibitors and protective agents.
    Herraiz T
    J Enzyme Inhib Med Chem; 2012 Dec; 27(6):810-7. PubMed ID: 21992679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on ATP levels of mouse brain synaptosomes.
    Scotcher KP; Irwin I; DeLanney LE; Langston JW; Di Monte D
    J Neurochem; 1990 Apr; 54(4):1295-301. PubMed ID: 2313288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protection against acute MPTP-induced dopamine depletion in mice by adenosine A1 agonist.
    Lau YS; Mouradian MM
    J Neurochem; 1993 Feb; 60(2):768-71. PubMed ID: 8419552
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
    Sirinathsinghji DJ; Heavens RP; McBride CS
    Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Lau YS; Fung YK; Trobough KL; Cashman JR; Wilson JA
    Neurotoxicology; 1991; 12(2):189-99. PubMed ID: 1956580
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole, protects against methamphetamine-induced neurotoxicity in vivo.
    Itzhak Y; Ali SF
    J Neurochem; 1996 Oct; 67(4):1770-3. PubMed ID: 8858965
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
    López A; Ortiz F; Doerrier C; Venegas C; Fernández-Ortiz M; Aranda P; Díaz-Casado ME; Fernández-Gil B; Barriocanal-Casado E; Escames G; López LC; Acuña-Castroviejo D
    PLoS One; 2017; 12(8):e0183090. PubMed ID: 28800639
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor.
    Joyce JN; Woolsey C; Ryoo H; Borwege S; Hagner D
    BMC Biol; 2004 Oct; 2():22. PubMed ID: 15473914
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clonidine suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced reductions of striatal dopamine and tyrosine hydroxylase activity in mice.
    Fornai F; Alessandrì MG; Fascetti F; Vaglini F; Corsini GU
    J Neurochem; 1995 Aug; 65(2):704-9. PubMed ID: 7616226
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase.
    Ferrante RJ; Hantraye P; Brouillet E; Beal MF
    Brain Res; 1999 Mar; 823(1-2):177-82. PubMed ID: 10095024
    [TBL] [Abstract][Full Text] [Related]  

  • 52. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
    Saporito MS; Brown EM; Miller MS; Carswell S
    J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase.
    Melamed E; Youdim MB
    Br J Pharmacol; 1985 Nov; 86(3):529-31. PubMed ID: 3877535
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
    Mitsumoto Y; Mori A
    Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidative stress induced by MPTP and MPP(+): selective vulnerability of cultured mouse astrocytes.
    Wong SS; Li RH; Stadlin A
    Brain Res; 1999 Jul; 836(1-2):237-44. PubMed ID: 10415427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anti-cancer agent SU4312 unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS.
    Cui W; Zhang Z; Li W; Hu S; Mak S; Zhang H; Han R; Yuan S; Li S; Sa F; Xu D; Lin Z; Zuo Z; Rong J; Ma ED; Choi TC; Lee SM; Han Y
    Br J Pharmacol; 2013 Mar; 168(5):1201-14. PubMed ID: 23062100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.
    Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
    J Neural Transm (Vienna); 2003 Oct; 110(10):1129-44. PubMed ID: 14523625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.